About Inovotion
Inovotion is a company based in La Tronche (France) founded in 2014. Inovotion offers products and services including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays. Inovotion operates in a competitive market with competitors including Altis Biosystems, Toxys, ATANIS Biotech, BioTalentum and Foresee Biosystems, among others.
- Headquarter La Tronche, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inovotion Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$57.05 K (USD), Grant
Jun 30, 2017
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inovotion
Inovotion offers a comprehensive portfolio of products and services, including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays.
Assays for evaluating drug efficacy and toxicity in oncology research.
Platform for studying tumor growth and metastasis in vivo models.
Services for assessing drug safety and target validation in medicine.
Funding Insights of Inovotion
Investors in Inovotion
Inovotion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Inovotion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inovotion
Investment portfolio details for Inovotion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inovotion
Detailed financials for Inovotion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inovotion Comparisons
Peer comparison for Inovotion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inovotion
Inovotion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, Toxys, ATANIS Biotech, BioTalentum and Foresee Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of invitro platform for drug testing
|
|
| Locked | Locked | Locked |
In vitro genotoxicity testing services are provided using proprietary technology.
|
|
| Locked | Locked | Locked |
Developer of a cell-based assay for the diagnosis of allergies
|
|
| Locked | Locked | Locked |
Human stem-cell technologies for drug testing and toxicology are provided.
|
|
| Locked | Locked | Locked |
Developer of in vitro assays for detection of potential toxicity in drug discovery
|
Detailed competitors of Inovotion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inovotion
Complete news archive for Inovotion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inovotion
Inovotion was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Inovotion is headquartered in La Tronche, France. It is registered at La Tronche, Auvergne-rhone-alpes, France.
Jean Viallet is the current CEO of Inovotion.
Inovotion was founded in 2014 in La Tronche, France, within the biotechnology sector focused on oncology. In vivo assays for efficacy and toxicity in drug discovery and development are offered by the company. Highly sensitive and reproducible assays for immuno-oncology programs are provided, along with monitoring of human tumor cell growth and metastatic dissemination. Operations support pharmaceutical research through these specialized services.
Inovotion's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.
Inovotion offers In Vivo Oncology Assays, CAM Technology, and Toxicity Assays.
Inovotion has 2 investors. Key investors include European Union, and EIC Fund.